Pharvaris B.V. (PHVS) PT Lowered to $74 at Citizens Ahead of Phase 3 Readout in Q3
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben lowered the price target on Pharvaris B.V. (NASDAQ: PHVS) to $74.00 (from $75.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
